Fig. 5.
Mechanism of action of infliximab. There is reduced polymorphonuclear-leucocyte trafficking after infliximab therapy in patients with RA (22).
Mechanism of action of infliximab. There is reduced polymorphonuclear-leucocyte trafficking after infliximab therapy in patients with RA (22).